ClinConnect ClinConnect Logo
Search / Trial NCT06847009

Effect of Acupressure on Sleep Quality in Hemodialysis Patients: a Randomized Controlled Trial

Launched by DIDEM LAFCI · Feb 21, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Hemodialysis Treatment Patient Nurse Acupressure Application Sleep Quality

ClinConnect Summary

This clinical trial is studying how acupressure, a gentle pressure technique, can improve sleep quality for patients undergoing hemodialysis treatment. Hemodialysis is a procedure that helps filter waste from the blood when the kidneys aren't working properly. The researchers want to see if applying acupressure can help these patients sleep better, since many struggle with sleep issues.

To participate in the study, you need to be at least 18 years old, receiving hemodialysis treatment three times a week for at least six months, and able to read, write, and understand Turkish. Participants must be alert, in good health, and able to communicate. Unfortunately, those with certain conditions, like psychiatric diseases or specific physical issues, won't be eligible for this trial. If you qualify and choose to take part, you’ll receive acupressure treatment, and researchers will monitor how it affects your sleep. This study is not yet recruiting participants, but it aims to provide valuable information on how alternative methods like acupressure could benefit patients on hemodialysis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Informed Voluntary Consent Form/Written Consent Form signed by the patient
  • Able to read, write, speak and understand Turkish
  • Over 18 years of age
  • Receiving HD treatment for at least 6 months
  • Receiving HD treatment 3 times a week
  • Conscious, fully oriented and cooperative, and open to communication
  • No vision, hearing and perception problems
  • General condition good and comfortable (vital signs within normal limits)
  • Exclusion Criteria:
  • Patients who do not sign the Informed Consent Form/Written Consent Form
  • Those who cannot read, write or understand Turkish
  • Those who are under 18 years of age
  • Those who have received HD treatment for less than 6 months
  • Those who receive HD treatment twice a week
  • Those who are unconscious, have incomplete orientation and cooperation and are closed to communication
  • Those who have vision, hearing and perception problems
  • Those whose general condition is not good
  • Those who have a wound or amputation in the lower extremity, rheumatoid arthritis or limb fracture
  • Those who have any psychiatric disease
  • Those who have Hepatitis B and Hepatitis C
  • Those who use any of the complementary and integrated methods

About Didem Lafci

Didem Lafci is a dedicated clinical trial sponsor specializing in the development and management of innovative therapeutic interventions. With a strong commitment to advancing medical research, the organization collaborates with leading research institutions and healthcare professionals to conduct rigorous clinical trials. Didem Lafci prioritizes patient safety and ethical standards, ensuring compliance with regulatory requirements while striving to deliver meaningful outcomes that enhance patient care. Through its focus on transparency and collaboration, Didem Lafci aims to contribute significantly to the advancement of medical science and the improvement of health outcomes.

Locations

Mersin, Yenişehir, Turkey

Mersin, , Turkey

Mersin, Yenişehir, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported